Sarepta Therapeutics, Inc. · NASDAQ:SRPT

Vanguard Portfolio Management LLC reported a 6.43% stake in Sarepta Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 29, 2026

Vanguard Portfolio Management LLC reported a 6.43% stake in Sarepta Therapeutics, Inc., 6,751,168 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).

Stake
6.43%
Shares
6,751,168
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Portfolio Management6.43%6,751,168

Source

View original at SEC

Related